scholarly article | Q13442814 |
P2093 | author name string | Howley PM | |
Baker CC | |||
P2860 | cites work | Identification of the human papilloma virus-1a E4 gene products | Q24531494 |
Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose | Q24563043 | ||
A new method for sequencing DNA | Q24605576 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Studies on transformation of Escherichia coli with plasmids | Q27860598 | ||
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes | Q27860600 | ||
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I | Q27860885 | ||
E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene | Q28286988 | ||
A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells | Q29614815 | ||
High-Efficiency Cloning of Full-Length cDNA | Q29618285 | ||
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter | Q29620405 | ||
Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions | Q33928568 | ||
A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state | Q33929025 | ||
The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens | Q33929781 | ||
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences | Q35358646 | ||
Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity | Q35595257 | ||
Bovine papillomavirus contains multiple transforming genes | Q36422987 | ||
Localization and analysis of bovine papillomavirus type 1 transforming functions | Q36895431 | ||
Fine structure of the cottontail rabbit papillomavirus mRNAs expressed in the transplantable VX2 carcinoma | Q36898991 | ||
Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors | Q36899614 | ||
Transcriptional organization of bovine papillomavirus type 1 | Q36907874 | ||
Complementation of a bovine papilloma virus low-copy-number mutant: evidence for a temporal requirement of the complementing gene | Q36910968 | ||
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription | Q36940690 | ||
Identification of a second transforming region in bovine papillomavirus DNA | Q37580560 | ||
Bovine Papilloma Virus Transcription: Polyadenylated RNA Species and Assessment of the Direction of Transcription | Q40141793 | ||
Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus. | Q41571316 | ||
Differential regulation of papilloma virus early gene expression in transformed fibroblasts and carcinoma cell lines | Q42223757 | ||
The primary structure and genetic organization of the bovine papillomavirus type 1 genome | Q42665433 | ||
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. | Q43821035 | ||
Characterization of the bovine papilloma virus plasmid maintenance sequences | Q45797228 | ||
Multiple Point Mutations Affecting the Simian Virus 40 Enhancer | Q45799028 | ||
Virus-specific transcription in bovine papillomavirus-transformed mouse cells | Q45800470 | ||
Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids | Q45836263 | ||
Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product | Q45838465 | ||
Messenger RNAs from the transforming region of bovine papilloma virus type I. | Q45838602 | ||
Promoters and heterogeneous 5' termini of the messenger RNAs of adenovirus serotype 2. | Q48409232 | ||
Multiple specific contacts between a mammalian transcription factor and its cognate promoters | Q53747083 | ||
Dissociation of transforming and trans-activation functions for bovine papillomavirus type 1. | Q54151145 | ||
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA | Q59083203 | ||
Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. | Q64956444 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1027-1035 | |
P577 | publication date | 1987-04-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues | |
P478 | volume | 6 |
Q36798097 | A bovine papillomavirus E1-related protein binds specifically to bovine papillomavirus DNA |
Q36793349 | A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor |
Q36687296 | A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter |
Q35882933 | A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention |
Q36825691 | Accumulation of RNA homologous to human papillomavirus type 16 open reading frames in genital precancers |
Q40065013 | An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor |
Q36820734 | An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels |
Q35979296 | Analysis of HPV-1 E4 gene expression using epitope-defined antibodies |
Q36295157 | Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells |
Q33638736 | Bovine papilloma virus-transformed cells contain multiple E2 proteins |
Q36889637 | Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region |
Q36881338 | Bovine papillomavirus type 1 E1 replication-defective mutants are altered in their transcriptional regulation |
Q42612859 | Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. |
Q33292465 | Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB |
Q35409389 | Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs |
Q37159116 | Bovine papillomavirus type 4 L1 gene transfection in a Drosophila S2 cell expression system: absence of L1 protein expression |
Q36767326 | Cell-heritable stages of tumor progression in transgenic mice harboring the bovine papillomavirus type 1 genome |
Q39857705 | Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation |
Q42287823 | Characterisation of early and late bovine papillomavirus protein expression in equine sarcoids |
Q36680070 | Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter |
Q35226050 | Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function |
Q67698418 | Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts |
Q40663368 | Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines |
Q34770066 | Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations |
Q33847281 | Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression |
Q35849203 | Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. |
Q36652359 | Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters |
Q33853697 | Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression |
Q39604102 | Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes |
Q36917130 | Enhancers and trans-acting E2 transcriptional factors of papillomaviruses |
Q36872236 | Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1. |
Q36829530 | Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells |
Q37078121 | Genetic modification of neural stem cells |
Q42649713 | Genome of the European elk papillomavirus (EEPV). |
Q36655698 | Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells. |
Q37899326 | Human papillomavirus infections of the genital tract |
Q33905805 | Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts |
Q36917086 | Human papillomavirus types 6 and 11 mRNAs from genital condylomata acuminata |
Q36650345 | Identification and characterization of novel promoters in the genome of human papillomavirus type 18. |
Q35858861 | Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA |
Q36792104 | Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity |
Q36653942 | Importance of the bovine papillomavirus P2443 promoter in the regulation of E2 and E5 expression |
Q36793417 | Induction of bovine papillomavirus E2 gene expression and early region transcription by cell growth arrest: correlation with viral DNA amplification and evidence for differential promoter induction. |
Q33839721 | L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation |
Q36697994 | Late promoter of human papillomavirus type 8 and its regulation |
Q34348189 | Life cycle heterogeneity in animal models of human papillomavirus-associated disease |
Q37071223 | Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue |
Q36827496 | Loss of bovine papillomavirus DNA replication control in growth-arrested transformed cells. |
Q34717843 | Messenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells |
Q40562275 | Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1). |
Q40448842 | Multiple cooperative interactions constrain BPV-1 E2 dependent activation of transcription |
Q36636113 | Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells |
Q35849102 | Mutational analysis of the 18-base-pair inverted repeat element at the bovine papillomavirus origin of replication: identification of critical sequences for E1 binding and in vivo replication |
Q36920313 | Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1. |
Q36781513 | Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer. |
Q36781994 | Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms |
Q36780194 | Open reading frames E6 and E7 of bovine papillomavirus type 1 are both required for full transformation of mouse C127 cells |
Q33814170 | Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability |
Q36801624 | Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants |
Q36829708 | Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia |
Q36877486 | Promoters of bovine papillomavirus type 1: in vitro activity and utilization |
Q42008115 | R-loop mapping of RNA transcripts from bovine papillomavirus type 4. |
Q39036718 | Recent advances in preclinical model systems for papillomaviruses |
Q40038156 | Regulation of DNA synthesis in division-arrested mouse C127 cells permissive for bovine papillomavirus DNA amplification |
Q37125682 | Regulation of bovine papillomavirus type 1 gene expression by RNA processing |
Q38332780 | Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells |
Q33648895 | Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle |
Q36651655 | Repression of bovine papillomavirus type 1 transcription by the E1 replication protein. |
Q37256346 | Role of papillomaviruses |
Q35864749 | Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor |
Q36000905 | Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain |
Q36663019 | Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions |
Q36548636 | Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers |
Q36866660 | Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses |
Q33783002 | Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. |
Q41353765 | The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region |
Q42631894 | The E2 protein of human papillomavirus type 16. Over-expression and purification of an active transcriptional regulator |
Q36812512 | The E2 transactivator of bovine papillomavirus type 1 is expressed from multiple promoters. |
Q42271216 | The E4 protein; structure, function and patterns of expression |
Q40141212 | The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells |
Q36793464 | The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element |
Q36989421 | The biology and significance of human papillomavirus infections in the genital tract. |
Q36062091 | The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulation |
Q33932448 | The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency |
Q35977741 | The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity |
Q36638250 | The genomes of the animal papillomaviruses European elk papillomavirus, deer papillomavirus, and reindeer papillomavirus contain a novel transforming gene (E9) near the early polyadenylation site |
Q36551242 | The human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated region |
Q36831106 | The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. |
Q39549244 | The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein. |
Q26750643 | The reciprocal regulation between splicing and 3'-end processing |
Q35977695 | The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer |
Q33929973 | The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones |
Q34293109 | The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo |
Q48230838 | Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study. |
Q33929980 | Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis |
Q36830039 | Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells |
Q68279933 | Tumor Progression in Transgenic Mice Containing the Bovine Papillomavirus Genome |
Q33645669 | Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation |
Q39336561 | Viral and cellular oncogenes in papillomavirus-associated cancers |
Q69834669 | [Warts and viruses] |
Q37509240 | tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes |
Search more.